A woman from Greater Poland has taken the bold step of suing the Polish Treasury, claiming that complications from the COVID-19 vaccine have seriously impacted her health and daily life. Her demand? A hefty PLN 201,000 in compensation. The lawsuit has now been submitted to the court, with a hearing set for December.
The lawsuit raises eyebrows, not only because it touches on the controversial topic of COVID-19 vaccinations but also because of the potential legal ramifications. If this case sets a precedent, it could open the floodgates to a slew of similar claims, potentially costing the government millions—or even more. And that’s the real concern.
The claimant argues that after receiving the vaccine, she experienced adverse health effects, which continue to impact her daily life. While it’s unclear what specific ailments she suffers from, her legal team is holding the government responsible for what they see as an “unintended consequence” of a state-endorsed health policy.
The Polish government, represented by the Prosecutor General’s Office, isn’t backing down. They’ve filed a motion to dismiss the case outright, suggesting that any admission of liability could be disastrous. If the court rules in favor of the woman, it could set a dangerous precedent, paving the way for a wave of compensation claims that could drain public funds.
With mixed opinions on COVID-19 vaccines still swirling, this case could reignite heated debates. Despite health authorities and many doctors dismissing concerns as conspiracy theories, the fact remains that a significant chunk of the population remains skeptical. In 2024, only about 59.2% of Poles had received at least one dose—far short of the government’s 80% goal.
All eyes will be on the December 13 hearing. The stakes are high—not just for the claimant, but for the government. Could this case be the first domino to fall, triggering an avalanche of legal claims that could cripple the state’s finances? Time will tell, but if the court rules in her favor, the fallout could be massive.